ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2014

Aug 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2014-08-11

Reporting Person: Bencich John (CFO and PFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-11	Stock Option (right to buy)	$3.30	A	40000	Acquired	2024-08-11	Common Stock (40000)	Direct
2014-08-11	Restricted Stock Unit (RSU)	$	A	20000	Acquired		Common Stock (20000)	Direct

Footnotes

F1: The options vest monthly over 48 months, commencing on September 11, 2014.

F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement.

F3: 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 11, 2014; and (ii) the first day thereafter during which the issuer's trading window is open.

F4: The RSUs expire 30 days from the date they vest.